跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Non-exclusive License) Technology Transfer Enterprise Selection Announcement - Purified mAbs with Specificity against SARS-CoV-2 Spike Protein
Date of Announcement
2020-09-17
 

Subject

(Non-exclusive License) Technology Transfer Enterprise Selection Announcement - Purified mAbs with Specificity against SARS-CoV-2 Spike Protein

Content

  • Technology:

Purified mAbs with Specificity against SARS-CoV-2 Spike Protein

  • Provider:

Professor Shih-Chung Chang/ Department of Biochemical Science and Technology

  • Enterprise Eligibility

1. Industry Category: Biotechnology

2. Required Technical Know-how: Biomedical testing and R&D capability

3. Required Machinery and Equipment: Electrophoresis equipment, PCR amplification device, and other biomedical testing-related devices

4. Required Research or Technical Staff:  Professional R&D personnel at the master or doctoral levels with backgrounds relevant to biochemical science and technology

5. Other Requirements: No specific restrictions

 

The university's regulations relevant to technology transfer shall be complied with for matters not aforementioned.

 

  • How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.

Contact Person

Sierra Wang

TEL: +886-2-33669954

Email: sierrawang@ntu.edu.tw

File download:
Technology Transfer Enterprise Selection Announcement - Purified mAbs with Specificity against SARS-CoV-2 Spike Protein
File size: 404kb